These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
376 related articles for article (PubMed ID: 29434344)
1. Identification of microRNAs differentially expressed in glioblastoma stem-like cells and their association with patient survival. Sana J; Busek P; Fadrus P; Besse A; Radova L; Vecera M; Reguli S; Stollinova Sromova L; Hilser M; Lipina R; Lakomy R; Kren L; Smrcka M; Sedo A; Slaby O Sci Rep; 2018 Feb; 8(1):2836. PubMed ID: 29434344 [TBL] [Abstract][Full Text] [Related]
2. A three-microRNA signature identifies two subtypes of glioblastoma patients with different clinical outcomes. Marziali G; Buccarelli M; Giuliani A; Ilari R; Grande S; Palma A; D'Alessandris QG; Martini M; Biffoni M; Pallini R; Ricci-Vitiani L Mol Oncol; 2017 Sep; 11(9):1115-1129. PubMed ID: 28248456 [TBL] [Abstract][Full Text] [Related]
3. Combined expressional analysis, bioinformatics and targeted proteomics identify new potential therapeutic targets in glioblastoma stem cells. Stangeland B; Mughal AA; Grieg Z; Sandberg CJ; Joel M; Nygård S; Meling T; Murrell W; Vik Mo EO; Langmoen IA Oncotarget; 2015 Sep; 6(28):26192-215. PubMed ID: 26295306 [TBL] [Abstract][Full Text] [Related]
4. Genome-wide methylomic and transcriptomic analyses identify subtype-specific epigenetic signatures commonly dysregulated in glioma stem cells and glioblastoma. Pangeni RP; Zhang Z; Alvarez AA; Wan X; Sastry N; Lu S; Shi T; Huang T; Lei CX; James CD; Kessler JA; Brennan CW; Nakano I; Lu X; Hu B; Zhang W; Cheng SY Epigenetics; 2018; 13(4):432-448. PubMed ID: 29927689 [TBL] [Abstract][Full Text] [Related]
5. miR-135b suppresses tumorigenesis in glioblastoma stem-like cells impairing proliferation, migration and self-renewal. Lulli V; Buccarelli M; Martini M; Signore M; Biffoni M; Giannetti S; Morgante L; Marziali G; Ilari R; Pagliuca A; Larocca LM; De Maria R; Pallini R; Ricci-Vitiani L Oncotarget; 2015 Nov; 6(35):37241-56. PubMed ID: 26437223 [TBL] [Abstract][Full Text] [Related]
6. Isocitrate dehydrogenase 1 (IDH1) mutation-specific microRNA signature predicts favorable prognosis in glioblastoma patients with IDH1 wild type. Wang Z; Bao Z; Yan W; You G; Wang Y; Li X; Zhang W J Exp Clin Cancer Res; 2013 Aug; 32(1):59. PubMed ID: 23988086 [TBL] [Abstract][Full Text] [Related]
7. Differential expression of MicroRNAs in patients with glioblastoma after concomitant chemoradiotherapy. Park EC; Kim G; Jung J; Wang K; Lee S; Jeon SS; Lee ZW; Kim SI; Kim S; Oh YT; Shin JH; Jang HS; Choi BO; Kim GH OMICS; 2013 May; 17(5):259-68. PubMed ID: 23586679 [TBL] [Abstract][Full Text] [Related]
8. Molecular heterogeneity in a patient-derived glioblastoma xenoline is regulated by different cancer stem cell populations. Garner JM; Ellison DW; Finkelstein D; Ganguly D; Du Z; Sims M; Yang CH; Interiano RB; Davidoff AM; Pfeffer LM PLoS One; 2015; 10(5):e0125838. PubMed ID: 25955030 [TBL] [Abstract][Full Text] [Related]
9. Risk Score based on microRNA expression signature is independent prognostic classifier of glioblastoma patients. Sana J; Radova L; Lakomy R; Kren L; Fadrus P; Smrcka M; Besse A; Nekvindova J; Hermanova M; Jancalek R; Svoboda M; Hajduch M; Slampa P; Vyzula R; Slaby O Carcinogenesis; 2014 Dec; 35(12):2756-62. PubMed ID: 25322872 [TBL] [Abstract][Full Text] [Related]
10. Comparative analyses identify molecular signature of MRI-classified SVZ-associated glioblastoma. Lin CA; Rhodes CT; Lin C; Phillips JJ; Berger MS Cell Cycle; 2017 Apr; 16(8):765-775. PubMed ID: 28278055 [TBL] [Abstract][Full Text] [Related]
11. Global MicroRNA Expression Profiling Identifies Unique MicroRNA Pattern of Radioresistant Glioblastoma Cells. Ondracek J; Fadrus P; Sana J; Besse A; Loja T; Vecera M; Radova L; Smrcka M; Slampa P; Slaby O Anticancer Res; 2017 Mar; 37(3):1099-1104. PubMed ID: 28314270 [TBL] [Abstract][Full Text] [Related]
12. Ribosomal Proteins RPS11 and RPS20, Two Stress-Response Markers of Glioblastoma Stem Cells, Are Novel Predictors of Poor Prognosis in Glioblastoma Patients. Yong WH; Shabihkhani M; Telesca D; Yang S; Tso JL; Menjivar JC; Wei B; Lucey GM; Mareninov S; Chen Z; Liau LM; Lai A; Nelson SF; Cloughesy TF; Tso CL PLoS One; 2015; 10(10):e0141334. PubMed ID: 26506620 [TBL] [Abstract][Full Text] [Related]
13. A novel gene signature based on five glioblastoma stem-like cell relevant genes predicts the survival of primary glioblastoma. Chai R; Zhang K; Wang K; Li G; Huang R; Zhao Z; Liu Y; Chen J J Cancer Res Clin Oncol; 2018 Mar; 144(3):439-447. PubMed ID: 29299749 [TBL] [Abstract][Full Text] [Related]
14. Identification of a Prognostic Hypoxia-Associated Gene Set in IDH-Mutant Glioma. Dao Trong P; Rösch S; Mairbäurl H; Pusch S; Unterberg A; Herold-Mende C; Warta R Int J Mol Sci; 2018 Sep; 19(10):. PubMed ID: 30257451 [TBL] [Abstract][Full Text] [Related]
15. Integrative analysis of cell adhesion molecules in glioblastoma identified prostaglandin F2 receptor inhibitor (PTGFRN) as an essential gene. Mala U; Baral TK; Somasundaram K BMC Cancer; 2022 Jun; 22(1):642. PubMed ID: 35690717 [TBL] [Abstract][Full Text] [Related]
16. The analysis of miRNA expression profiling datasets reveals inverse microRNA patterns in glioblastoma and Alzheimer's disease. Candido S; Lupo G; Pennisi M; Basile MS; Anfuso CD; Petralia MC; Gattuso G; Vivarelli S; Spandidos DA; Libra M; Falzone L Oncol Rep; 2019 Sep; 42(3):911-922. PubMed ID: 31322245 [TBL] [Abstract][Full Text] [Related]
17. Dexamethasone-mediated oncogenicity in vitro and in an animal model of glioblastoma. Luedi MM; Singh SK; Mosley JC; Hassan ISA; Hatami M; Gumin J; Andereggen L; Sulman EP; Lang FF; Stueber F; Fuller GN; Colen RR; Zinn PO J Neurosurg; 2018 Dec; 129(6):1446-1455. PubMed ID: 29328002 [TBL] [Abstract][Full Text] [Related]
18. MicroRNAs in glioblastoma pathogenesis and therapy: A comprehensive review. Ahir BK; Ozer H; Engelhard HH; Lakka SS Crit Rev Oncol Hematol; 2017 Dec; 120():22-33. PubMed ID: 29198335 [TBL] [Abstract][Full Text] [Related]
19. Involvement of miRNAs in the differentiation of human glioblastoma multiforme stem-like cells. Aldaz B; Sagardoy A; Nogueira L; Guruceaga E; Grande L; Huse JT; Aznar MA; Díez-Valle R; Tejada-Solís S; Alonso MM; Fernandez-Luna JL; Martinez-Climent JA; Malumbres R PLoS One; 2013; 8(10):e77098. PubMed ID: 24155920 [TBL] [Abstract][Full Text] [Related]